Albert David Limited Share Price NSE India S.E.

ALBERTDAVD

INE155C01010

Pharmaceuticals

Delayed NSE India S.E. 11:01:23 21/08/2026 BST			5-day change	1st Jan Change
864.15 ^INR	+0.12%		+6.36%	+17.32%

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI

Valuation: Albert David Limited

Market Cap	4.94B 51.61M 44.18M 41.22M 37.83M 71.08M 72.48M 489M 191M 2.47B 194M 190M 8.19B	P/E 2025	26.9x	P/E 2026	-224x
Enterprise Value	2.66B 27.78M 23.78M 22.19M 20.36M 38.26M 39.01M 263M 103M 1.33B 104M 102M 4.41B	EV / Sales 2025	0.67x	EV / Sales 2026	0.32x
Free-Float	35.96%	Yield 2025	0.62%	Yield 2026	0.85%

* Estimated data More valuation ratios

Latest news : Albert David Limited

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI
08-06	Albert David Limited Announces Resignation of Kuntal Ganguly from Head- R&D, Effective August 5, 2026	CI
05-30	Albert David Limited Announces Resignation of Chandra Bhushan Thakur from Head-Operations, Effective May 29, 2026	CI
05-12	Albert David appoints Amit Mahla as CEO effective May 12	RE
05-12	Albert David Limited Announces Appointment of Amit Mahla as the Chief Executive Officer with Effect from May 12, 2026	CI
05-12	Albert David Limited Announces Appointment of Amit Mahla as the Key Managerial Personnel with Effect from May 12, 2026	CI
05-12	Albert David Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-11	Albert David Limited announces Annual dividend, payable on September 05, 2026	CI
02-11	Albert David Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
12-19	Albert David says Umesh Manohar Kunte resigns as MD, CEO	RE
12-18	Albert David says Umesh Manohar Kunte resigns as managing director and CEO	RE
12-18	Albert David Limited Announces Resignation of CEO Umesh Manohar Kunte, Effective December 18, 2025	CI

More news

Managers and Directors: Albert David Limited

Manager	Title	Age	Since
Amit Mahla CEO	Chief Executive Officer	52	11/05/2026
Ranadeep Bhattacharya DFI	Director of Finance/CFO	-	30/11/2020
Lalit Lohia CMP	Compliance Officer	-	-

Director	Title	Age	Since
Arun Kumar Kothari CHM	Chairman	73	29/12/2009
Prabhawati Devi Kothari BRD	Director/Board Member	68	30/03/2014
Monjori Mitra BRD	Director/Board Member	64	23/08/2020

More insiders

Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.

Employees

1,476

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
21/08/26	₹864.15	+0.12%	8,329
20/08/26	₹863.15	+2.81%	13,723
19/08/26	₹839.55	+0.78%	14,295
18/08/26	₹833.05	+3.34%	17,562
17/08/26	₹806.10	-0.79%	9,575

Delayed Quote NSE India S.E.

More quotes

The best tools reserved for subscribers to boost the performance of your investments!

1 day	+0.12%
1 week	+6.36%
Current month	+25.37%
1 month	+24.11%
3 months	+22.35%
6 months	+19.76%
Current year	+17.32%

1 week	791.2	870
1 month	678	870
Current year	579.9	870
1 year	579.9	903
3 years	579.9	1,753.95
5 years	486.85	1,753.95
10 years	263	1,753.95

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALBERT DAVID LIMITED	+0.12%	+6.36%	-	-	51.61M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.08%	-1.43%	+15.99%	+67.26%	47.74B
OTSUKA HOLDINGS CO., LTD.	-3.21%	+1.37%	+52.36%	+125.75%	41.7B
CIPLA LIMITED	-0.40%	-1.23%	-10.08%	+16.08%	12.14B
ZYDUS LIFESCIENCES LIMITED	+1.11%	-1.34%	+13.61%	+71.49%	11.55B
KRKA, D. D.	0.00%	0.00%	+30.00%	+147.62%	9.18B
GEDEON RICHTER	-0.39%	+0.62%	+19.93%	+39.54%	7.54B
ONO PHARMACEUTICAL CO., LTD.	-1.35%	+0.74%	+47.03%	-11.93%	7.35B
GLENMARK PHARMACEUTICALS LIMITED	-0.64%	-0.02%	+19.42%	+199.06%	6.88B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+2.65%	-3.55%	-31.27%	+24.03%	5.72B
Average	-0.22%	-0.63%	+17.44%	+75.43%	16.64B
Weighted average by Cap.	-0.88%	-0.54%	+24.75%	+83.77%

	2025	2026
Net sales	3.46B 36.14M 30.94M 28.87M 26.49M 49.77M 50.75M 342M 133M 1.73B 136M 133M 5.74B	3.34B 34.86M 29.85M 27.85M 25.56M 48.02M 48.97M 330M 129M 1.67B 131M 128M 5.53B
Net income	172M 1.8M 1.54M 1.44M 1.32M 2.48M 2.52M 17.04M 6.64M 86.2M 6.75M 6.6M 285M	-14.95M -156K -134K -125K -115K -215K -219K -1.48M -577K -7.49M -587K -574K -24.8M
Net Debt	-2.31B -24.18M -20.7M -19.31M -17.72M -33.3M -33.96M -229M -89.32M -1.16B -90.78M -88.81M -3.84B	-2.28B -23.83M -20.4M -19.04M -17.47M -32.82M -33.47M -226M -88.03M -1.14B -89.47M -87.53M -3.78B

Albert David Limited Share Price NSE India S.E.

Stocks

ALBERTDAVD

INE155C01010

Pharmaceuticals

Valuation: Albert David Limited

Chart: Albert David Limited

Latest news : Albert David Limited

Quotes and Performance

Course Extremes

Managers and Directors: Albert David Limited

Generic Pharmaceuticals

Financials

Company Profile

Quotes